More than 50,000 Americans die each year from colorectal cancer, and the number is growing rapidly for those under the age of 50. The tragic thing is that most of these deaths could have—and should have—been prevented.
March Forth is an effort to focus resources in geographic areas across the country to shine a light on colorectal cancer. Starting with Philadelphia, we plan to save lives and increase screening for colorectal cancer, one of the most preventable cancers there is!
Help us save lives today! Your contribution helps us to build the programs that will support lifesaving screening in communities throughout the country.
A comprehensive plan to save lives
March Forth offers a four-pronged strategy to drive screening rates above 80%. Implementing this massive outreach campaign, aimed at patients, physicians, and the systems they navigate, will result in upwards of an additional 100,000 individuals screened annually, saving hundreds of lives.
Employ multitouch outreach to ensure patients are current on screenings
Vulnerable community outreach
Conduct outbound navigation for vulnerable populations and support the cost of screening and follow-up care
Marketing campaign to drive awareness
Multimedia campaigns for patients and physicians to highlight the importance of screening, testing options, and to emphasize there is no “best” test
Health system education
Educate physicians and health systems on colorectal cancer screening options and ensure dissemination of current screening information and patient education during and after the appointment
Why start in Philadelphia?
Philadelphia’s large population of at-risk individuals are drastically under-screened for colorectal cancer in comparison with other major cities. This combined with world-class healthcare institutions and the presence of our many supporters and advocates in the community make Philadelphia the ideal choice for our pilot program.
Philadelphia Colorectal Cancer Screening Facts
of Philadelphians live below the poverty line - this can mean lower access to care, higher illness, and mortality
In some Philadelphia communities, the screening rate is below 40% (more than 25% lower than the national average)
Philadelphians are diagnosed with colorectal cancer every year
More than 300 people in Philadelphia die annually from colorectal cancer – at least 200 of these deaths are preventable with lifesaving screening
To save lives in Philadelphia and beyond…
Investment over two years
Additional Philadelphia screenings
300 additional lives saved
and thousands can avoid needless suffering
Managing Partner, Proof VC
John M. Daly, MD, FACS
Harry C. Donahoo Professor, Surgery, Lewis Katz School of Medicine at Temple University
Surgical Director, William Maul Measey Institute for Clinical Simulation and Patient Safety
Emeritus Dean, Lewis Katz School of Medicine at Temple University
Attending Surgeon, Fox Chase Cancer Center
Managing Director, American Securities
Joseph A. Frick
Senior Advisor at Diversified Search, prior CEO of Independence Blue Cross
Kevin T. Lewis
Senior Partner, McKinsey & Company